%0 Journal Article
%T Mammary Myofibroblastoma in a Transgender Patient on Feminizing Hormones: Literature Review and Case Report
%A Carolyn Wolf-Gould
%A Jane O'Bryan
%A Yoshiro Matsuo
%J Archive of "Transgender Health".
%D 2018
%R 10.1089/trgh.2017.0026
%X Purpose: Defining the risk of neoplasia associated with gender-affirming hormone therapy (GAHT) is a priority for transgender medical research. The purposes of this article are to present a unique case of breast neoplasia in a transgender individual and to review the existing evidence base on GAHT as a potential risk for breast pathology
%K breast neoplasms
%K hormones
%K myofibroblastoma
%K transgender adult
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770133/